In healthcare, utilization management means checking and approving medical services, procedures, or medicines covered by a health plan. Prior authorization is an important part of this. It means payers must approve services before they are given to control costs and keep care good.
AI systems help speed up these checks by looking at patient data, guessing what services might be needed, and automating approval or denial decisions. But new federal and state rules say AI cannot be the only one making decisions. Human clinical reviewers must check decisions, especially when they can negatively affect patient care.
Federal rules like the Centers for Medicare & Medicaid Services (CMS) 2023 Medicare Advantage Policy Rule and the 2024 Interoperability and Prior Authorization final rule set clear standards for using AI in utilization management and prior authorization. These rules say AI can help but cannot replace human judgment. Also, prior authorization decisions must be shared quickly: within 72 hours for urgent cases and seven days for regular requests by January 1, 2027. Patient privacy laws like HIPAA and fairness in decisions are also required.
Some states such as Colorado, California, Illinois, and New York have made or suggested laws that require clear information about AI’s role in decisions, human review of AI results, checking how AI affects outcomes, and rules against discrimination.
Testing AI systems well before using them is key to stopping bias and wrong results. This means checking how the AI works using data that represents the patients it will help. If this is not done, wrong choices, delays, or unfair treatment of some groups can happen.
Healthcare groups should do side-by-side testing where AI results are compared directly to decisions made by skilled human reviewers. This helps find differences, bias, or errors the AI might cause. For example, if AI learns from data that isn’t complete or fair, it might treat minorities or vulnerable people unfairly by guessing they need less care than they actually do.
Medical administrators and IT managers in the U.S. should make sure vendors show they follow evidence-based standards. Groups like the Utilization Review Accreditation Commission (URAC) or the National Committee for Quality Assurance (NCQA) set these standards. This makes sure AI meets quality rules and legal demands.
Before using AI, vendors must be clear about what the AI can and cannot do. This helps healthcare workers know when human judgment is needed.
Testing AI once is not enough. It is also important to keep checking that AI works well and follows rules after it starts being used. This means auditing AI’s performance with real data, watching how accurate its decisions are, how fast it works, the rate of bad events, and if patients or providers complain.
CMS rules require Medicare Advantage groups and payers to regularly review AI decisions. They check for changes in AI performance that may happen because of changes in population health, data quality, or updates to AI models.
Monitoring means healthcare groups keep detailed records and do tests to find weak points that could lead to security problems or wrong data that harm AI results.
Also, AI needs to be checked often to make sure it follows current clinical rules and good medical practices. These checks help healthcare groups change or retrain AI when new rules or standards come out.
Data bias is a tough problem in healthcare AI. AI trained on old data may copy unfair differences in care access or results. This can cause some patients to have their services delayed or denied unfairly.
To avoid this, AI systems must be trained on data that is complete, diverse, and balanced. This means including different age groups, races, genders, and income levels.
Regulators, including states like Colorado and California, require impact checks for high-risk AI systems. Patients must give informed consent when AI is used, and it must be clear when AI helps make decisions. These rules support accountability and protect patient rights.
Medical administrators should ask for clear information on how AI decisions are made. This includes which parts of the data matter most and the chance for patients to ask for human reviews of AI decisions.
AI systems handle sensitive patient data, so protecting this data is very important. Healthcare groups must make sure vendors follow privacy laws like HIPAA and others such as GDPR if needed.
Data should be encrypted when stored and when sent. Access must be controlled by role-based controls (RBAC), multi-factor authentication (MFA) should be used, and regular security tests should be done to stop unauthorized access or data leaks.
HITRUST offers an AI Assurance Program with standards from groups like the National Institute of Standards and Technology (NIST) and the International Organization for Standardization (ISO). This helps healthcare groups build safe and clear AI systems that reduce ethical risks.
Since vendors often make and handle AI tools, healthcare administrators should check their ethics, how they manage data, and how they respond to problems.
AI automation is changing how healthcare works in the front office. For example, Simbo AI helps answer phone calls automatically, cutting down on manual work and human mistakes in scheduling and talking with patients.
In utilization management, AI mixed with automated workflows can cut down the time and paperwork needed for prior authorization. AI tools can fill in forms ahead, automatically find missing information, and send alerts when a human reviewer is needed.
However, automation must follow federal and state rules that require human checks for medical decisions. Medical administrators and IT managers can use AI automation to:
Good AI workflow automation can help healthcare reduce delays, improve patient satisfaction, and meet deadline rules. It also lets staff focus on tasks needing human judgment.
Following laws is always changing in AI healthcare utilization management (UM) and prior authorization (PA). On October 30, 2023, President Joe Biden signed an Executive Order asking the Department of Health and Human Services (HHS) to make rules about using AI in healthcare delivery and payment.
At the same time, CMS rules say AI helps but does not replace human decisions in clinical care. Human involvement is required. State laws want transparency and protection from AI bias or unfair treatment.
Healthcare groups must keep up with these rules and work with regulators, tech providers, and patient groups to make ethical policies and strong AI management plans.
Medical administrators and IT managers must do regular audits and checks of AI systems and train staff on following rules. These actions help lower legal risks and build trust with patients and providers.
Using AI in utilization management works best when healthcare providers, payers, regulators, vendors, and patients work closely together.
Clear communication about how AI affects decisions and patient outcomes builds trust. It lets patients use their rights, like asking for human reviews or making appeals.
Healthcare groups should make clear rules for writing down AI use and giving easy explanations of AI-made decisions to patients and providers.
Also, working with vendors to regularly check AI for bias, accuracy, and rule compliance helps keep AI use ethical.
To avoid bias and errors in AI-based utilization management, healthcare administrators and IT managers in the U.S. should:
By doing these, medical practices can use AI well while protecting patient care, data privacy, and meeting legal requirements in utilization management.
The use of AI in utilization management is an important step in U.S. healthcare. But only with careful testing, ongoing checks, and responsible use can AI fully improve workflows and patient results without losing fairness, openness, or trust. Technology providers like Simbo AI help by making tools that follow these goals, supporting healthcare as it works in a complex and regulated environment.
The Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program final rule issued by CMS mandates that Medicare Advantage organizations ensure medical necessity determinations consider the specific individual’s circumstances and comply with HIPAA. AI can assist but cannot solely determine medical necessity, ensuring fairness and mechanisms to contest AI decisions.
Effective by January 1, 2027, this rule requires payers to implement a Prior Authorization Application Programming Interface (API) to streamline the PA process. Decisions must be sent within 72 hours for urgent requests and seven days for standard requests. AI may be deployed to comply with timing but providers must remain involved in decision-making.
Signed on October 30, 2023, it mandates HHS to develop policies and regulatory actions for AI use in healthcare, including predictive and generative AI in healthcare delivery, financing, and patient experience. It also calls for AI assurance policies to enable evaluation and oversight of AI healthcare tools.
Examples include Colorado’s 2023 act requiring impact assessments and anti-discrimination measures for AI systems used in healthcare decisions; California’s AB 3030 requiring patient consent for AI use and Senate Bill 1120 mandating human review of UM decisions; Illinois’ H2472 requiring clinical peer review of adverse determinations and evidence-based criteria; and pending New York legislation requiring insurance disclosures and algorithm certification.
Plans must navigate varying state and federal regulations, ensure AI systems do not result in discrimination, guarantee that clinical reviewers oversee adverse decisions, maintain transparency about AI use, and implement mechanisms for reviewing and contesting AI-generated determinations to remain compliant across jurisdictions.
Regulations emphasize that qualified human clinical reviewers must oversee and validate adverse decisions related to medical necessity to prevent sole reliance on AI algorithms, assuring fairness, accuracy, and compliance with legal standards in UM/PA processes.
AI systems must be tested on representative datasets to avoid bias and inaccuracies, with side-by-side comparisons to clinical reviewer decisions. After deployment, continuous monitoring of decision accuracy, timeliness, patient/provider complaints, and effectiveness is critical to detect and correct weaknesses.
Insurers and healthcare providers should disclose AI involvement in decisions to patients and providers, including how AI contributed to decisions, ensuring individuals are informed and entitled to appeal AI-generated determinations, promoting trust and accountability.
Engagement with regulators, healthcare providers, patient groups, and technology experts helps navigate regulatory complexities, develop ethical best practices, and foster trust, ensuring AI in UM/PA improves decision quality while adhering to evolving standards and patient rights.
Continuous review of regulatory changes, internal quality assurance, periodic audits for algorithm performance, adherence to clinical guidelines, and responsiveness to complaints are necessary to ensure AI systems remain compliant, fair, and effective in prior authorization and utilization management.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
